Science Explorer Back to mapMap

Most cited papers from Orange County Research Center

What are the most cited papers from Orange County Research Center?

The most cited paper from Orange County Research Center is "Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia" (Jennifer G. Robinson, Bettina S. Nedergaard, William John Rogers et al., 2014), with 507 citations. Next come "Anti-PCSK9 Monotherapy for Hypercholesterolemia" (415) and "Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia" (376).

Showing 50 of 60 papers. Every paper with more than 33 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia Jennifer G. Robinson, Bettina S. Nedergaard, William John Rogers et al. · JAMA 13 May 2014 507
2 Anti-PCSK9 Monotherapy for Hypercholesterolemia Michael J. Koren, Pernille Lundqvist, Michael A. Bolognese et al. · Journal of the American College of Cardiology Open access 29 Mar 2014 415
3 Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Kevin T. McVary, Claus G. Roehrborn, Jed C. Kaminetsky et al. · The Journal of Urology 24 Mar 2007 376
4 Sildenafil Citrate Improves Erectile Function and Urinary Symptoms in Men With Erectile Dysfunction and Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized, Double-Blind Trial Kevin T. McVary, William B. Monnig, Joseph L. Camps et al. · The Journal of Urology 11 Feb 2007 352
5 Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension Gary F. Mitchell, Yves Lacourcière, Jean-Pascal Ouellet et al. · Circulation Open access 16 Sep 2003 325
6 Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) Michael J. Koren, Patrick M. Moriarty, Seth J. Baum et al. · Nature Medicine 2022 235
7 Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension Gary F. Mitchell, Joseph L. Izzo, Yves Lacourcière et al. · Circulation 25 Jun 2002 224
8 Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial Vlad Ratziu et al. · Nature Medicine Open access Oct 2021 222
9 A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Murielle M. Véniant, Shu-Chen Lu, Larissa I. Atangan et al. · Nature Metabolism Open access 5 Feb 2024 214
10 Advanced glycation end-product cross-link breakersA novel approach to cardiovascular pathologies related to the aging process George L. Bakris, A Bank, D KASS et al. · American Journal of Hypertension Dec 2004 209
11 A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer Channing Judith Paller, Xiquan Ye, Paulina Woźniak et al. · Prostate Cancer and Prostatic Diseases Open access 12 Jun 2012 186
12 Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension Gary F. Mitchell, Paul R. Conlin, Mark E. Dunlap et al. · Hypertension Open access 11 Dec 2007 183
13 Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia Christie Mitchell Ballantyne, Joel Neutel, Anne Cropp et al. · The American Journal of Cardiology Open access 11 Feb 2015 171
14 Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials Anne Marie Wallace, Linda K. Han, Stephen P. Povoski et al. · Annals of Surgical Oncology Open access 16 Mar 2013 115
15 Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors Peter William Blumencranz, Pat W. Whitworth, Kenneth Deck et al. · The American Journal of Surgery 7 Sep 2007 105
16 Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab Annette Magdalene Langer-Gould, Jessica B. Smith, Edlin G. Gonzales et al. · International Journal of Infectious Diseases Open access 5 Aug 2020 99
17 A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients Edward M. Messing, Jason Gee, Daniel R. Saltzstein et al. · Cancer Prevention Research Open access Feb 2012 96
18 A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide Matthew R. Weir, Willa A. Hsueh, Shawna D. Nesbitt et al. · Journal of Clinical Hypertension Open access 5 Feb 2011 85
19 Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management Jonathan Wade Goldman, Melody A. Mendenhall, Sarah R. Rettinger · The Oncologist Open access 29 Jul 2016 83
20 Tissue fixation security in transosseous rotator cuff repairs: A mechanical comparison of simple versus mattress sutures Stephen S. Burkhart, Scott P. Fischer, Wesley M. Nottage et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery Dec 1996 81
21 The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial Joel M. Neutel, Elijah Saunders, George L. Bakris et al. · Journal of Clinical Hypertension Open access Oct 2005 78
22 Bariatric surgery in patients older than 65 years is safe and effective Brian B. Quebbemann, David R. Engstrom, T. Siegfried et al. · Surgery for Obesity and Related Diseases 25 Jun 2005 74
23 Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss James R. Berenson, Ori Yellin, Ralph Vincent Boccia et al. · Clinical Cancer Research 30 Sep 2008 71
24 Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID ‐19, in Subjects With Renal Impairment Sima S. Toussi, Joel M. Neutel, Jesús Navarro et al. · Clinical Pharmacology & Therapeutics Open access 17 Jun 2022 68
25 International Importance of Robust Breast Device Registries Rodney D. Cooter, S. B. Barker, Sean Michael Carroll et al. · Plastic & Reconstructive Surgery 28 Jan 2015 65
26 Tadalafil Improved Erectile Function at Twenty‐Four and Thirty‐Six Hours After Dosing in Men With Erectile Dysfunction: US Trial Jay M. Young, Robert Feldman, Stephen M. Auerbach et al. · Journal of Andrology Open access 2 May 2005 59
27 Efficacy and Safety of Coadministered Amlodipine and Atorvastatin in Patients With Hypertension and Dyslipidemia: Results of the AVALON Trial Franz H. Messerli, George L. Bakris, René Ferrera et al. · Journal of Clinical Hypertension Open access Aug 2006 57
28 Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration Amir H. Kashani et al. · Stem Cell Reports Open access 3 Feb 2022 55
29 Lack of Effect of Fluticasone Propionate Aqueous Nasal Spray on the Hypothalamic-Pituitary-Adrenal Axis in 2- and 3-Year-Old Patients Stanley Paul Galant, Isaac Reuven Melamed, Anjuli S. Nayak et al. · PEDIATRICS Jul 2003 53
30 Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients Joel M. Neutel · Current Medical Research and Opinion 9 Jul 2008 52
31 Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer Aaron Spitz, Jay M. Young, Lois M. Larsen et al. · Prostate Cancer and Prostatic Diseases Open access 25 Oct 2011 52
32 Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study Joel M. Neutel, David H.G. Smith, Michael A. Weber et al. · Journal of Clinical Hypertension Open access Nov 2005 52
33 Telmisartan/Hydrochlorothiazide in Comparison with Losartan/Hydrochlorothiazide in Managing Patients with Mild-to-Moderate Hypertension Joel M. Neutel, Thomas W Littlejohn, Steven G. Chrysant et al. · Hypertension Research Open access 2005 51
34 Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy William E. Berger, Mark B. Abelson, P.J. Gomes et al. · Annals of Allergy Asthma & Immunology Oct 2005 47
35 Social System Psychotherapy Ε. Mansell Pattison · American Journal of Psychotherapy Jul 1973 47
36 The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study Joel M. Neutel, William H. Bestermann, Eric M. Dyess et al. · Journal of Clinical Hypertension Open access 2009 46
37 Thioridazine plasma levels and clinical response Louis A. Gottschalk, Robert Biener, Ernest Pascal Noble et al. · Comprehensive Psychiatry Jul 1975 44
38 Use of an Olmesartan Medoxomil‐Based Treatment Algorithm for Hypertension Control Joel M. Neutel, David H.G. Smith, Micheal A. Weber et al. · Journal of Clinical Hypertension Open access Apr 2004 43
39 Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials Yves Lacourcière, Joel M. Neutel, Helmut Schumacher · Clinical Therapeutics Nov 2005 43
40 Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study Joseph L. Izzo, Joel M. Neutel, Tonous N Silfani et al. · Journal of Clinical Hypertension Open access 2007 43
41 Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study Henry A. Punzi, Joel M. Neutel, Dean J. Kereiakes et al. · Therapeutic Advances in Cardiovascular Disease 2 Jun 2010 41
42 Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action Joel M. Neutel, David H.G. Smith · Cardiovascular Therapeutics 2 Nov 2012 41
43 A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients Peter J. Winkle, Steven R. Goldsmith, Michael J. Koren et al. · Cardiovascular Drugs and Therapy Open access 23 Apr 2022 40
44 The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials Philippe Gosse, Joel M. Neutel, Helmut Schumacher et al. · Blood Pressure Monitoring 11 May 2007 40
45 Pharmacology of cardiovascular chronotherapeutic agents David J. Smith · American Journal of Hypertension Sep 2001 40
46 A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs David M. Vail et al. · Journal of Veterinary Internal Medicine Open access 6 Mar 2012 40
47 Antihypertensive Efficacy of Irbesartan/HCTZ in Men and Women With the Metabolic Syndrome and Type 2 Diabetes James R. Sowers, Joel M. Neutel, Elijah Saunders et al. · Journal of Clinical Hypertension Open access Jul 2006 40
48 Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials Bryan Williams, Yves Lacourcière, Helmut Schumacher et al. · Journal of Human Hypertension 19 Feb 2009 40
49 The role of combination therapy in the management of hypertension Joel M. Neutel · Nephrology Dialysis Transplantation 19 May 2006 38
50 Oral insulin ( ORMD ‐0801) in type 2 diabetes mellitus: A dose‐finding 12‐week randomized placebo‐controlled study Roy Eldor, Bruce H. Francis, Alexander Fleming et al. · Diabetes Obesity and Metabolism 25 Oct 2022 37

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.